Pivotal Research Initiates USANA Health Sciences With Buy

Analysts at Pivotal Research initiated coverage on USANA Health Sciences

with a Buy rating. The target price for USANA Health Sciences is set to $100. USANA Health Sciences shares have dropped 7.92% over the past 52 weeks, while the S&P 500 index has surged 8.14% in the same period. USANA Health Sciences' shares surged 0.40% to close at $80.36 on Friday.